查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607131

真菌性角膜炎治療市場：按給藥途徑、分銷管道分類 - 全球預測 2025-2030

Fungal Keratitis Treatment Market by Route of Administration (Injection, Oral, Topical), Distribution Channel (Drug Stores, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，真菌性角膜炎治療市值為85731萬美元，預計2024年將達到89125萬美元，複合年成長率為5.18%，到2030年將達到122131萬美元。

真菌性角膜炎是一種會引起角膜發炎的眼部感染疾病，主要由鐮刀菌、麴菌和念珠菌等真菌引起。真菌感染疾病盛行率不斷上升、人們對眼睛健康的認知不斷增強以及醫療基礎設施的發展推動了治療市場的發展。治療包括預防視力障礙和改善眼部健康，其用途包括抗真菌眼藥水、口服抗真菌治療以及嚴重病例的手術介入。最終用途包括醫院、眼科診所和門診手術中心。關鍵的成長要素包括早期檢測診斷技術的進步以及隱形眼鏡使用的增加，這增加了感染的風險。對個人化醫療和基因治療日益成長的需求正在透過專注於新型抗真菌藥物和標靶藥物輸送系統的研究來創造商機。遠端醫療的廣泛使用為遠距離診斷和處方提供了平台，增加了服務不足地區的服務。至於挑戰，診斷延遲、誤診和抗真菌藥物抗藥性是主要障礙，阻礙了市場成長。 FDA核准的抗真菌藥物的供應有限也阻礙了市場擴張。監管障礙和高昂的處理成本進一步增加了複雜性。抗真菌肽研究的創新、聯合治療的配方以及生物分解性的眼部藥物輸送系統的開發是有前景的投資領域。動態療法的研究和應用奈米技術來增強現有藥物的療效也提供了潛力。市場的本質特徵是製藥巨頭和利基生物技術公司之間的競爭動態推動了適度成長。強調與學術機構的研究和發展合作將被證明是無價的。總體而言，雖然仍然存在重大挑戰，但配方和藥物傳輸機制的持續研究和技術進步有望推動未來的成長並擴大全球治療的可及性。

主要市場統計
基準年[2023] 85731萬美元
預計年份 [2024] 8.9125 億美元
預測年份 [2030] 1,221.31 百萬美元
複合年成長率（%） 5.18%

市場動態：快速發展的真菌性角膜炎治療市場的關鍵市場洞察

供需的動態交互作用正在改變真菌性角膜炎治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 已開發國家因真菌性角膜炎導致失明和視力障礙的人數增加
    • 氣候溫暖地區真菌性角膜炎的發生率增加
    • 隱形眼鏡的快速普及和缺乏正確使用
  • 市場限制因素
    • 對真菌性角膜炎治療併發症的擔憂
  • 市場機會
    • 積極的局部抗真菌療法的出現
    • 增加治療真菌性角膜炎的新產品開發
  • 市場挑戰
    • 醫療手術失敗導致真菌復發的病例增加

波特五力：開拓真菌性角膜炎治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解真菌性角膜炎治療市場的外部影響

外部宏觀環境因素在塑造真菌性角膜炎治療市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解真菌性角膜炎治療市場的競爭格局

真菌性角膜炎治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣性真菌性角膜炎治療市場供應商的績效評估

FPNV定位矩陣是評估真菌性角膜炎治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了真菌性角膜炎治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，真菌性角膜炎治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在已開發國家，由真菌性角膜炎引起的失明和視力障礙正在增加
      • 溫帶氣候地區真菌性角膜炎的發生率增加
      • 隱形眼鏡使用率快速增加但缺乏正確使用
    • 抑制因素
      • 對真菌性角膜炎治療併發症的擔憂
    • 機會
      • 積極的局部抗真菌療法的出現
      • 增加治療真菌性角膜炎的新產品開發
    • 任務
      • 導致真菌復發的失敗醫療手術的增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 真菌性角膜炎治療市場：依給藥途徑

  • 注射
  • 口服
  • 話題

第7章 真菌性角膜炎治療市場：依分銷管道分類

  • 藥局
  • 醫院

第8章北美和南美真菌性角膜炎治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區真菌性角膜炎治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的真菌性角膜炎治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aurolab
  • Bausch Health Companies Inc.
  • Mallinckrodt LLC
  • Merck KGaA
  • Novartis AG
  • Ora, Inc.
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.
Product Code: MRR-FD3F12D54247

The Fungal Keratitis Treatment Market was valued at USD 857.31 million in 2023, expected to reach USD 891.25 million in 2024, and is projected to grow at a CAGR of 5.18%, to USD 1,221.31 million by 2030.

Fungal keratitis is an eye infection causing corneal inflammation, primarily due to fungi such as Fusarium, Aspergillus, and Candida. The treatment market is driven by the rising prevalence of fungal infections, increased awareness about eye health, and growing healthcare infrastructure. Necessarily, these treatments prevent vision impairment and improve ocular health, with applications ranging from topical antifungal eye drops, oral antifungal medications, to surgical interventions in severe cases. End-use encompasses hospitals, eye clinics, and ambulatory surgical centers. Key growth factors include advancements in diagnostics for early detection and the rise in contact lens usage, which heightens infection risks. Opportunities emerge from increased demand for personalized medicine and gene therapy, emphasizing research into novel antifungal agents and targeted drug delivery systems. Adoption of telemedicine further provides a platform for remote diagnosis and prescription, expanding reach in underserved regions. Challenges hinder market growth, with delayed diagnosis, misdiagnosis, and resistance to antifungal drugs posing significant hurdles. Limited availability of FDA-approved antifungal treatments for the condition further constrains market expansion. Regulatory barriers and high cost of treatment add layers of complexity. Innovations in antifungal peptide research, formulation of combination therapies, and development of biodegradable ocular drug delivery systems present promising areas for investment. Exploring photodynamic therapy and enhancing the efficacy of existing drugs via nanotechnology applications also offer potential avenues. The nature of the market is characterized by gradual growth with competitive dynamics driven by both pharmaceutical giants and niche biotech firms. Strong emphasis on collaboration with academic institutions for R&D could prove invaluable. Overall, while substantial challenges remain, ongoing research and technological advancements in drug formulation and delivery mechanisms promise to catalyze future growth and expand treatment access globally.

KEY MARKET STATISTICS
Base Year [2023] USD 857.31 million
Estimated Year [2024] USD 891.25 million
Forecast Year [2030] USD 1,221.31 million
CAGR (%) 5.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fungal Keratitis Treatment Market

The Fungal Keratitis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing blindness and visual impairment in developed countries due to fungal keratitis
    • Rising incidence of fungal keratitis in regions with temperate climates
    • Exponential use of contact lens and lack of their proper application
  • Market Restraints
    • Concerns related to complications of fungal keratitis treatment
  • Market Opportunities
    • Emergence of aggressive topical antifungal therapy for treatment
    • Increasing new product developments in the treatment of fungal keratitis
  • Market Challenges
    • Increasing number of failed medical surgeries resulting in reappearance of fungus

Porter's Five Forces: A Strategic Tool for Navigating the Fungal Keratitis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fungal Keratitis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fungal Keratitis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fungal Keratitis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fungal Keratitis Treatment Market

A detailed market share analysis in the Fungal Keratitis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fungal Keratitis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fungal Keratitis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fungal Keratitis Treatment Market

A strategic analysis of the Fungal Keratitis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fungal Keratitis Treatment Market, highlighting leading vendors and their innovative profiles. These include Aurolab, Bausch Health Companies Inc., Mallinckrodt LLC, Merck KGaA, Novartis AG, Ora, Inc., Pfizer Inc., and Santen Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Fungal Keratitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Injection, Oral, and Topical.
  • Based on Distribution Channel, market is studied across Drug Stores and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing blindness and visual impairment in developed countries due to fungal keratitis
      • 5.1.1.2. Rising incidence of fungal keratitis in regions with temperate climates
      • 5.1.1.3. Exponential use of contact lens and lack of their proper application
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to complications of fungal keratitis treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of aggressive topical antifungal therapy for treatment
      • 5.1.3.2. Increasing new product developments in the treatment of fungal keratitis
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing number of failed medical surgeries resulting in reappearance of fungus
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fungal Keratitis Treatment Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Oral
  • 6.4. Topical

7. Fungal Keratitis Treatment Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. Hospitals

8. Americas Fungal Keratitis Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fungal Keratitis Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fungal Keratitis Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aurolab
  • 2. Bausch Health Companies Inc.
  • 3. Mallinckrodt LLC
  • 4. Merck KGaA
  • 5. Novartis AG
  • 6. Ora, Inc.
  • 7. Pfizer Inc.
  • 8. Santen Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. FUNGAL KERATITIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. FUNGAL KERATITIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FUNGAL KERATITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FUNGAL KERATITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FUNGAL KERATITIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FUNGAL KERATITIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM FUNGAL KERATITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM FUNGAL KERATITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. FUNGAL KERATITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. FUNGAL KERATITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023